시장조사 보고서 : 세계의 칼륨 채널 차단제 시장예측 2021년-2026년

■ 영문 제목 : Global Potassium Channel Blocker Market Growth 2021-2026
	■ 상품코드 : LPI-2108K200022 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 166 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 칼륨 채널 차단제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (임상, 비 임상, 비활성)와 용도별 시장규모 (진료소, 병원) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 칼륨 채널 차단제 시장 점유율
- 지역별 칼륨 채널 차단제 시장규모
- 주요지역의 종류별 시장규모 (임상, 비 임상, 비활성)
- 주요지역의 용도별 시장규모 (진료소, 병원)
- 미주의 칼륨 채널 차단제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 칼륨 채널 차단제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 칼륨 채널 차단제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 칼륨 채널 차단제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 칼륨 채널 차단제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Potassium Channel Blocker will have significant change from previous year. By the most conservative estimates of global Potassium Channel Blocker market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Potassium Channel Blocker market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Potassium Channel Blocker market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Clinical
Non-clinical
Inactive

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Clinic
Hospital

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Kineta
Sevion Therapeutics
Cono Genetix
KPI Therapeutics
Amgen
Agenus bio
Bristol-Myers Squibb
Enumeral
F-star
GlaxoSmithKline
North Coast Bio
Novartis
Regeneron

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Potassium Channel Blocker Consumption 2016-2026
2.1.2 Potassium Channel Blocker Consumption CAGR by Region
2.2 Potassium Channel Blocker Segment by Type
2.2.1 Clinical
2.2.2 Non-clinical
2.2.3 Inactive
2.3 Potassium Channel Blocker Sales by Type
2.3.1 Global Potassium Channel Blocker Sales Market Share by Type (2016-2021)
2.3.2 Global Potassium Channel Blocker Revenue and Market Share by Type (2016-2021)
2.3.3 Global Potassium Channel Blocker Sale Price by Type (2016-2021)
2.4 Potassium Channel Blocker Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.5 Potassium Channel Blocker Sales by Application
2.5.1 Global Potassium Channel Blocker Sale Market Share by Application (2016-2021)
2.5.2 Global Potassium Channel Blocker Revenue and Market Share by Application (2016-2021)
2.5.3 Global Potassium Channel Blocker Sale Price by Application (2016-2021)

3 Global Potassium Channel Blocker by Company
3.1 Global Potassium Channel Blocker Sales Market Share by Company
3.1.1 Global Potassium Channel Blocker Sales by Company (2019-2021)
3.1.2 Global Potassium Channel Blocker Sales Market Share by Company (2019-2021)
3.2 Global Potassium Channel Blocker Revenue Market Share by Company
3.2.1 Global Potassium Channel Blocker Revenue by Company (2019-2021)
3.2.2 Global Potassium Channel Blocker Revenue Market Share by Company (2019-2021)
3.3 Global Potassium Channel Blocker Sale Price by Company
3.4 Global Manufacturers Potassium Channel Blocker Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Potassium Channel Blocker Product Location Distribution
3.4.2 Players Potassium Channel Blocker Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Potassium Channel Blocker by Region
4.1 Global Potassium Channel Blocker by Region
4.1.1 Global Potassium Channel Blocker Sales by Region
4.1.2 Global Potassium Channel Blocker Revenue by Region
4.2 Americas Potassium Channel Blocker Sales Growth
4.3 APAC Potassium Channel Blocker Sales Growth
4.4 Europe Potassium Channel Blocker Sales Growth
4.5 Middle East & Africa Potassium Channel Blocker Sales Growth

5 Americas
5.1 Americas Potassium Channel Blocker Sales by Country
5.1.1 Americas Potassium Channel Blocker Sales by Country (2016-2021)
5.1.2 Americas Potassium Channel Blocker Revenue by Country (2016-2021)
5.2 Americas Potassium Channel Blocker Sales by Type
5.3 Americas Potassium Channel Blocker Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Potassium Channel Blocker Sales by Region
6.1.1 APAC Potassium Channel Blocker Sales by Region (2016-2021)
6.1.2 APAC Potassium Channel Blocker Revenue by Region (2016-2021)
6.2 APAC Potassium Channel Blocker Sales by Type
6.3 APAC Potassium Channel Blocker Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Potassium Channel Blocker by Country
7.1.1 Europe Potassium Channel Blocker Sales by Country (2016-2021)
7.1.2 Europe Potassium Channel Blocker Revenue by Country (2016-2021)
7.2 Europe Potassium Channel Blocker Sales by Type
7.3 Europe Potassium Channel Blocker Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Potassium Channel Blocker by Country
8.1.1 Middle East & Africa Potassium Channel Blocker Sales by Country (2016-2021)
8.1.2 Middle East & Africa Potassium Channel Blocker Revenue by Country (2016-2021)
8.2 Middle East & Africa Potassium Channel Blocker Sales by Type
8.3 Middle East & Africa Potassium Channel Blocker Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Potassium Channel Blocker Distributors
10.3 Potassium Channel Blocker Customer

11 Global Potassium Channel Blocker Market Forecast
11.1 Global Potassium Channel Blocker Forecast by Region
11.1.1 Global Potassium Channel Blocker Forecast by Regions (2021-2026)
11.2.2 Global Potassium Channel Blocker Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Potassium Channel Blocker Forecast by Type
11.7 Global Potassium Channel Blocker Forecast by Application

12 Key Players Analysis
12.1 Kineta
12.1.1 Kineta Kineta Company Information
12.1.2 Kineta Potassium Channel Blocker Product Offered
12.1.3 Kineta Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Kineta Main Business Overview
12.1.5 Kineta Latest Developments
12.2 Sevion Therapeutics
12.2.1 Sevion Therapeutics Company Information
12.2.2 Sevion Therapeutics Potassium Channel Blocker Product Offered
12.2.3 Sevion Therapeutics Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sevion Therapeutics Main Business Overview
12.2.5 Sevion Therapeutics Latest Developments
12.3 Cono Genetix
12.3.1 Cono Genetix Company Information
12.3.2 Cono Genetix Potassium Channel Blocker Product Offered
12.3.3 Cono Genetix Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Cono Genetix Main Business Overview
12.3.5 Cono Genetix Latest Developments
12.4 KPI Therapeutics
12.4.1 KPI Therapeutics Company Information
12.4.2 KPI Therapeutics Potassium Channel Blocker Product Offered
12.4.3 KPI Therapeutics Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 KPI Therapeutics Main Business Overview
12.4.5 KPI Therapeutics Latest Developments
12.5 Amgen
12.5.1 Amgen Company Information
12.5.2 Amgen Potassium Channel Blocker Product Offered
12.5.3 Amgen Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Amgen Main Business Overview
12.5.5 Amgen Latest Developments
12.6 Agenus bio
12.6.1 Agenus bio Company Information
12.6.2 Agenus bio Potassium Channel Blocker Product Offered
12.6.3 Agenus bio Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Agenus bio Main Business Overview
12.6.5 Agenus bio Latest Developments
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Information
12.7.2 Bristol-Myers Squibb Potassium Channel Blocker Product Offered
12.7.3 Bristol-Myers Squibb Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Bristol-Myers Squibb Main Business Overview
12.7.5 Bristol-Myers Squibb Latest Developments
12.8 Enumeral
12.8.1 Enumeral Company Information
12.8.2 Enumeral Potassium Channel Blocker Product Offered
12.8.3 Enumeral Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Enumeral Main Business Overview
12.8.5 Enumeral Latest Developments
12.9 F-star
12.9.1 F-star Company Information
12.9.2 F-star Potassium Channel Blocker Product Offered
12.9.3 F-star Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 F-star Main Business Overview
12.9.5 F-star Latest Developments
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Company Information
12.10.2 GlaxoSmithKline Potassium Channel Blocker Product Offered
12.10.3 GlaxoSmithKline Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 GlaxoSmithKline Main Business Overview
12.10.5 GlaxoSmithKline Latest Developments
12.11 North Coast Bio
12.11.1 North Coast Bio Company Information
12.11.2 North Coast Bio Potassium Channel Blocker Product Offered
12.11.3 North Coast Bio Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 North Coast Bio Main Business Overview
12.11.5 North Coast Bio Latest Developments
12.12 Novartis
12.12.1 Novartis Company Information
12.12.2 Novartis Potassium Channel Blocker Product Offered
12.12.3 Novartis Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Novartis Main Business Overview
12.12.5 Novartis Latest Developments
12.13 Regeneron
12.13.1 Regeneron Company Information
12.13.2 Regeneron Potassium Channel Blocker Product Offered
12.13.3 Regeneron Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Regeneron Main Business Overview
12.13.5 Regeneron Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Potassium Channel Blocker Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Clinical
Table 3. Major Players of Non-clinical
Table 4. Major Players of Inactive
Table 5. Global Potassium Channel Blocker Sales by Type (2016-2021) & (K MT)
Table 6. Global Potassium Channel Blocker Sales Market Share by Type (2016-2021)
Table 7. Global Potassium Channel Blocker Revenue by Type (2016-2021) & ($ million)
Table 8. Global Potassium Channel Blocker Revenue Market Share by Type (2016-2021)
Table 9. Global Potassium Channel Blocker Sale Price by Type (2016-2021)
Table 10. Global Potassium Channel Blocker Sales by Application (2016-2021) & (K MT)
Table 11. Global Potassium Channel Blocker Sales Market Share by Application (2016-2021)
Table 12. Global Potassium Channel Blocker Value by Application (2016-2021)
Table 13. Global Potassium Channel Blocker Revenue Market Share by Application (2016-2021)
Table 14. Global Potassium Channel Blocker Sale Price by Application (2016-2021)
Table 15. Global Potassium Channel Blocker Sales by Company (2019-2021) & (K MT)
Table 16. Global Potassium Channel Blocker Sales Market Share by Company (2019-2021)
Table 17. Global Potassium Channel Blocker Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Potassium Channel Blocker Revenue Market Share by Company (2019-2021)
Table 19. Global Potassium Channel Blocker Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Potassium Channel Blocker Producing Area Distribution and Sales Area
Table 21. Players Potassium Channel Blocker Products Offered
Table 22. Potassium Channel Blocker Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Potassium Channel Blocker Sales by Region (2016-2021) (K MT)
Table 26. Global Potassium Channel Blocker Sales Market Share by Region (2016-2021)
Table 27. Global Potassium Channel Blocker Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Potassium Channel Blocker Revenue Market Share by Region (2016-2021)
Table 29. Americas Potassium Channel Blocker Sales by Country (2016-2021) & (K MT)
Table 30. Americas Potassium Channel Blocker Sales Market Share by Country (2016-2021)
Table 31. Americas Potassium Channel Blocker Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Potassium Channel Blocker Revenue Market Share by Country (2016-2021)
Table 33. Americas Potassium Channel Blocker Sales by Type (2016-2021) & (K MT)
Table 34. Americas Potassium Channel Blocker Sales Market Share by Type (2016-2021)
Table 35. Americas Potassium Channel Blocker Sales by Application (2016-2021) & (K MT)
Table 36. Americas Potassium Channel Blocker Sales Market Share by Application (2016-2021)
Table 37. APAC Potassium Channel Blocker Sales by Region (2016-2021) & (K MT)
Table 38. APAC Potassium Channel Blocker Sales Market Share by Region (2016-2021)
Table 39. APAC Potassium Channel Blocker Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Potassium Channel Blocker Revenue Market Share by Region (2016-2021)
Table 41. APAC Potassium Channel Blocker Sales by Type (2016-2021) & (K MT)
Table 42. APAC Potassium Channel Blocker Sales Market Share by Type (2016-2021)
Table 43. APAC Potassium Channel Blocker Sales by Application (2016-2021) & (K MT)
Table 44. APAC Potassium Channel Blocker Sales Market Share by Application (2016-2021)
Table 45. Europe Potassium Channel Blocker Sales by Country (2016-2021) & (K MT)
Table 46. Europe Potassium Channel Blocker Sales Market Share by Country (2016-2021)
Table 47. Europe Potassium Channel Blocker Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Potassium Channel Blocker Revenue Market Share by Country (2016-2021)
Table 49. Europe Potassium Channel Blocker Sales by Type (2016-2021) & (K MT)
Table 50. Europe Potassium Channel Blocker Sales Market Share by Type (2016-2021)
Table 51. Europe Potassium Channel Blocker Sales by Application (2016-2021) & (K MT)
Table 52. Europe Potassium Channel Blocker Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Potassium Channel Blocker Sales by Country (2016-2021) & (K MT)
Table 54. Middle East & Africa Potassium Channel Blocker Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Potassium Channel Blocker Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Potassium Channel Blocker Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Potassium Channel Blocker Sales by Type (2016-2021) & (K MT)
Table 58. Middle East & Africa Potassium Channel Blocker Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Potassium Channel Blocker Sales by Application (2016-2021) & (K MT)
Table 60. Middle East & Africa Potassium Channel Blocker Sales Market Share by Application (2016-2021)
Table 61. Global Potassium Channel Blocker Sales Forecast by Type (2021-2026) & (K MT)
Table 62. Global Potassium Channel Blocker Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Potassium Channel Blocker Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Potassium Channel Blocker Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Potassium Channel Blocker Sales Forecast by Application (2021-2026) & (K MT)
Table 66. Global Potassium Channel Blocker Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Potassium Channel Blocker Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Potassium Channel Blocker Revenue Market Share Forecast by Application (2021-2026)
Table 69. Kineta Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 70. Kineta Potassium Channel Blocker Product Offered
Table 71. Kineta Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 72. Kineta Main Business
Table 73. Kineta Latest Developments
Table 74. Sevion Therapeutics Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 75. Sevion Therapeutics Potassium Channel Blocker Product Offered
Table 76. Sevion Therapeutics Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 77. Sevion Therapeutics Main Business
Table 78. Sevion Therapeutics Latest Developments
Table 79. Cono Genetix Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 80. Cono Genetix Potassium Channel Blocker Product Offered
Table 81. Cono Genetix Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 82. Cono Genetix Main Business
Table 83. Cono Genetix Latest Developments
Table 84. KPI Therapeutics Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 85. KPI Therapeutics Potassium Channel Blocker Product Offered
Table 86. KPI Therapeutics Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 87. KPI Therapeutics Main Business
Table 88. KPI Therapeutics Latest Developments
Table 89. Amgen Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 90. Amgen Potassium Channel Blocker Product Offered
Table 91. Amgen Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 92. Amgen Main Business
Table 93. Amgen Latest Developments
Table 94. Agenus bio Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 95. Agenus bio Potassium Channel Blocker Product Offered
Table 96. Agenus bio Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 97. Agenus bio Main Business
Table 98. Agenus bio Latest Developments
Table 99. Bristol-Myers Squibb Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 100. Bristol-Myers Squibb Potassium Channel Blocker Product Offered
Table 101. Bristol-Myers Squibb Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 102. Bristol-Myers Squibb Main Business
Table 103. Bristol-Myers Squibb Latest Developments
Table 104. Enumeral Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 105. Enumeral Potassium Channel Blocker Product Offered
Table 106. Enumeral Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 107. Enumeral Main Business
Table 108. Enumeral Latest Developments
Table 109. F-star Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 110. F-star Potassium Channel Blocker Product Offered
Table 111. F-star Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 112. F-star Main Business
Table 113. F-star Latest Developments
Table 114. GlaxoSmithKline Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline Potassium Channel Blocker Product Offered
Table 116. GlaxoSmithKline Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 117. GlaxoSmithKline Main Business
Table 118. GlaxoSmithKline Latest Developments
Table 119. North Coast Bio Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 120. North Coast Bio Potassium Channel Blocker Product Offered
Table 121. North Coast Bio Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 122. North Coast Bio Main Business
Table 123. North Coast Bio Latest Developments
Table 124. Novartis Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis Potassium Channel Blocker Product Offered
Table 126. Novartis Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 127. Novartis Main Business
Table 128. Novartis Latest Developments
Table 129. Regeneron Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 130. Regeneron Potassium Channel Blocker Product Offered
Table 131. Regeneron Potassium Channel Blocker Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 132. Regeneron Main Business
Table 133. Regeneron Latest Developments
List of Figures
Figure 1. Picture of Potassium Channel Blocker
Figure 2. Potassium Channel Blocker Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Potassium Channel Blocker Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Potassium Channel Blocker Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Potassium Channel Blocker Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Clinical
Figure 10. Product Picture of Non-clinical
Figure 11. Product Picture of Inactive
Figure 12. Global Potassium Channel Blocker Sales Market Share by Type in 2020
Figure 13. Global Potassium Channel Blocker Revenue Market Share by Type (2016-2021)
Figure 14. Potassium Channel Blocker Consumed in Clinic
Figure 15. Global Potassium Channel Blocker Market: Clinic (2016-2021) & (K MT)
Figure 16. Potassium Channel Blocker Consumed in Hospital
Figure 17. Global Potassium Channel Blocker Market: Hospital (2016-2021) & (K MT)
Figure 18. Global Potassium Channel Blocker Sales Market Share by Application (2016-2021)
Figure 19. Global Potassium Channel Blocker Revenue Market Share by Application in 2020
Figure 20. Global Potassium Channel Blocker Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Potassium Channel Blocker Revenue Market Share by Company in 2020
Figure 22. Global Potassium Channel Blocker Sales Market Share by Regions (2016-2021)
Figure 23. Global Potassium Channel Blocker Revenue Market Share by Region in 2020
Figure 24. Americas Potassium Channel Blocker Sales 2016-2021 (K MT)
Figure 25. Americas Potassium Channel Blocker Revenue 2016-2021 ($ Millions)
Figure 26. APAC Potassium Channel Blocker Sales 2016-2021 (K MT)
Figure 27. APAC Potassium Channel Blocker Revenue 2016-2021 ($ Millions)
Figure 28. Europe Potassium Channel Blocker Sales 2016-2021 (K MT)
Figure 29. Europe Potassium Channel Blocker Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Potassium Channel Blocker Sales 2016-2021 (K MT)
Figure 31. Middle East & Africa Potassium Channel Blocker Revenue 2016-2021 ($ Millions)
Figure 32. Americas Potassium Channel Blocker Sales Market Share by Country in 2020
Figure 33. Americas Potassium Channel Blocker Revenue Market Share by Country in 2020
Figure 34. Americas Potassium Channel Blocker Sales Market Share by Type in 2020
Figure 35. Americas Potassium Channel Blocker Sales Market Share by Application in 2020
Figure 36. United States Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Potassium Channel Blocker Sales Market Share by Region in 2020
Figure 41. APAC Potassium Channel Blocker Revenue Market Share by Regions in 2020
Figure 42. APAC Potassium Channel Blocker Sales Market Share by Type in 2020
Figure 43. APAC Potassium Channel Blocker Sales Market Share by Application in 2020
Figure 44. China Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Potassium Channel Blocker Sales Market Share by Country in 2020
Figure 51. Europe Potassium Channel Blocker Revenue Market Share by Country in 2020
Figure 52. Europe Potassium Channel Blocker Sales Market Share by Type in 2020
Figure 53. Europe Potassium Channel Blocker Sales Market Share by Application in 2020
Figure 54. Germany Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Potassium Channel Blocker Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Potassium Channel Blocker Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Potassium Channel Blocker Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Potassium Channel Blocker Sales Market Share by Application in 2020
Figure 63. Egypt Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Potassium Channel Blocker Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles

※본 조사보고서 [세계의 칼륨 채널 차단제 시장예측 2021년-2026년] (코드 : LPI-2108K200022) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 칼륨 채널 차단제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 구연산 칼륨 시장예측 2021년-2026년
LPI-2108K200305 / LP Information / 2021년 8월 / 본 조사보고서는 구연산 칼륨의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Potassium Citrate will have significant change from previous year. By the most conservative estimates of global Potassium Citrate market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 527.3 million in 2019. Over...

세계의 수산화 칼륨 (KOH) 시장예측 2021년-2026년
LPI-2108K200152 / LP Information / 2021년 8월 / 본 조사보고서는 수산화 칼륨 (KOH)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Potassium Hydroxide (KOH) will have significant change from previous year. By the most conservative estimates of global Potassium Hydroxide (KOH) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 역추력 장치 시장예측 2021년-2026년
LPI-2108K201914 / LP Information / 2021년 8월 / 본 조사보고서는 역추력 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Thrust Reverser will have significant change from previous year. By the most conservative estimates of global Thrust Reverser market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1576.2 million in 2019. Over...

세계의 항소화성 궤양 치료약 시장예측 2021년-2026년
LPI-2108K201064 / LP Information / 2021년 8월 / 본 조사보고서는 항소화성 궤양 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 색상 유지제 시장예측 2021년-2026년
LPI-2108K200125 / LP Information / 2021년 8월 / 본 조사보고서는 색상 유지제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Colour Retention Agents will have significant change from previous year. By the most conservative estimates of global Colour Retention Agents market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 항공기 역 추진기 시장예측 2021년-2026년
LPI-2108K201038 / LP Information / 2021년 8월 / 본 조사보고서는 항공기 역 추진기의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Aircraft Reverse Thruster will have significant change from previous year. By the most conservative estimates of global Aircraft Reverse Thruster market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 여드름 치료제 시장예측 2021년-2026년
LPI-2108K202092 / LP Information / 2021년 8월 / 본 조사보고서는 여드름 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Acne Medication will have significant change from previous year. By the most conservative estimates of global Acne Medication market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 6748.3 million in 2019. Over...

세계의 4K 수술용 모니터 시장예측 2021년-2026년
LPI-2108K202133 / LP Information / 2021년 8월 / 본 조사보고서는 4K 수술용 모니터의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of 4K Surgical Monitors will have significant change from previous year. By the most conservative estimates of global 4K Surgical Monitors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 진단 해머 시장예측 2021년-2026년
LPI-2108K200051 / LP Information / 2021년 8월 / 본 조사보고서는 진단 해머의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Diagnostic Hammer will have significant change from previous year. By the most conservative estimates of global Diagnostic Hammer market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 본 해머 시장예측 2021년-2026년
LPI-2108K200042 / LP Information / 2021년 8월 / 본 조사보고서는 본 해머의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Bone Hammers will have significant change from previous year. By the most conservative estimates of global Bone Hammers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...